Clinical Trials Logo

Urologic Diseases clinical trials

View clinical trials related to Urologic Diseases.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06249243 Not yet recruiting - Clinical trials for Urinary System Disorders in IBD Patients

Affection of Renal and Urinary System in IBD Patients

Start date: February 20, 2024
Phase:
Study type: Observational

Detection and classification of different renal and urinary affection in patients with IBD that attended to Assist University Hospitals

NCT ID: NCT06059599 Not yet recruiting - Urologic Diseases Clinical Trials

Active Informed Consent: a New Solution to Improve and Objectively Test the Patient Understanding of Complex Surgical Procedures Proposals

Start date: June 2024
Phase: N/A
Study type: Interventional

This is an interventional, non-pharmacological, randomized controlled superiority study (RCT), multicenter, open label, parallel group. The aim is to evaluate the effectiveness of a new preoperative information method, based on multimedia tools and on the objective control of understanding by the patient candidate for spinal or urological surgery.

NCT ID: NCT05857020 Not yet recruiting - Chronic Pain Clinical Trials

Auricular Acupressure Therapy for Patients With IC/BPS

IC/BPS
Start date: July 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the feasibility of administering auricular acupressure for patients with interstitial cystitis/bladder pain syndrome (IC/BPS), and evaluating the efficacy of auricular acupressure to reduce pain scores and decrease pain medication usage over time.

NCT ID: NCT05748964 Not yet recruiting - Surgery Clinical Trials

Different Surgical Approaches for Treatment of UPJ Obstruction in Children: Prospective Randomized Clinical Trial

Start date: April 1, 2023
Phase:
Study type: Observational [Patient Registry]

This study aimed to evaluate the clinical efficacy of laparoscopic pyeloplasty (LP) for ureteropelvic junction obstruction (UPJO) via retroperitoneal and transperitoneal approaches.

NCT ID: NCT05694793 Not yet recruiting - Urologic Diseases Clinical Trials

Clinical Feasibility Assessment of Glean Urodynamics System

Start date: June 2024
Phase:
Study type: Observational

The goal of this prospective observational trial is to assess the safety and reliability of the Glean Urodynamics System (GUS) in adult females with lower urinary tract symptoms. The main question[s] it aims to answer are: • What is GUS's ability to safely and reliably conduct wireless, catheter-free monitoring of vesical pressure compared to the vesical pressures collected with conventional urodynamics? Participants will undergo a conventional urodynamics exam, a simultaneous urodynamics exam with GUS, ambulatory urodynamics with GUS, and extended home monitoring with GUS. Researchers will compare GUS data with that from a conventional urodynamics exam.

NCT ID: NCT05534399 Not yet recruiting - Clinical trials for Urinary Tract Disease

Antibiotic Strategy and Asymptomatic Bacteriuria in the Context of Intra-vesical Botulinum Toxin A Injections.

ANTIBIOBONTA
Start date: September 2022
Phase: N/A
Study type: Interventional

The study aims to demonstrate that the "thrifty antibiotic strategy" applied to MS or SCI patients with asymptomatic bacteriuria prior to BoNTA intravesical injections does not increase the rate of symptomatic post-injection UTIs compared to the current peri-operative antibiotic strategy. Patients included in the study will be randomized in two balanced-parallel groups, 4 days (+/- 2 days) before intra-vesical BoNTA injections. Group 1: Experimental group: "Sparing antibiotic strategy" No antibiotic therapy will be administered during the peri-operative period. Group 2: Control group: Recommendations - Peri-operative antibiotic strategy An antibiotic therapy will be administered during the peri-operative period. The antibiotic will be selected according to the type of bacteria isolated and the antibiotic susceptibility testing, and started two days before and pursued until two days following intra-vesical BoNTA injections. The main objective is to demonstrate the non-inferiority of "antibiotic saving strategy" compared to peri-operative antibiotic strategy (current recommendations) for occurrence of symptomatic UTI after intra-vesical BoNTA injections in the management of asymptomatic bacteriuria (AB) among multiple sclerosis (MS) and spinal cord injured (SCI) patients undergoing clean intermittent self-catheterization (CISC).

NCT ID: NCT05134675 Not yet recruiting - Addiction, Alcohol Clinical Trials

Does Homebrewing Beer Affect Urinary Tract Symptoms and Bladder Cancer

Start date: June 16, 2022
Phase:
Study type: Observational

In this study, investigators aim to reveal the harmful effects of increasing consumption of homemade beer in recent years on the urinary tract. The high amount of carbonyl compounds in the content of homemade beer has been proven by studies. In this study, which will be conducted in the form of a questionnaire, it is aimed to evaluate the effects of the consumption of homemade beer and the long-term exposure of the urinary system to carbonyl compounds.

NCT ID: NCT04564469 Not yet recruiting - Clinical trials for Renal Scan in Suspected Obstructive Uropathy in Adult Hydronephrotic Patient

Influence of Diuresis Timing (F+0 Vs F-15) on 99m Tc DTPA Renography for the Diagnosis of Suspected Obstructive Uropathy

Start date: October 1, 2020
Phase:
Study type: Observational

Evaluation of the influence of the diuretic injection timing (F+0 Vs F-15) on the dynamic 99mTc- DTPA renal scintigraphy for the diagnosis of suspected obstructive uropathy in adult hydronephrotic patients.

NCT ID: NCT03899298 Not yet recruiting - Stroke Clinical Trials

Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions

Start date: September 1, 2019
Phase: Phase 1
Study type: Interventional

To determine the safety and efficacy of Amniotic and Umbilical Cord Tissue for the treatment of the following condition categories: Orthopedic, Neurologic, Urologic, Autoimmune, Renal, Cardiac and Pulmonary Conditions. The hypotheses are that the treatments are not only extremely safe, but also statistically beneficial for all conditions. Outcomes will be determined by numerous valid outcome instruments that compile general quality of life information along with condition-specific information as well.

NCT ID: NCT03463239 Not yet recruiting - Urologic Diseases Clinical Trials

Bioengineered Penile Tissue Constructs for Irreversibly Damaged Penile Corpora

Start date: January 2025
Phase: Phase 1
Study type: Interventional

The primary objective of this clinical trial is to evaluate the safety of autologous engineered corpora cavernosa + albuginea constructs for treatment of complex penile deformities. Autologous endothelial and smooth muscle cells obtained from enrolled subjects' corpora cavernosa biopsy sample, will be culture expanded in vitro and used to seed decellularized corpora cavernosa + albuginea obtained from cadaveric-donors to create autologous bioengineered corpora cavernosa/albuginea constructs for repair of damaged penile tissues.